Adrian W. Quartel

Chief Medical Officer, Opexa Therapeutics.

Companies

SPRUCE BIOSCIENCES, INC.Chief Medical Officer Jul 29, 2026 to now¹
ZEVRA THERAPEUTICS, INC.Chief Medical Officer Mar 27, 2025 to now²
Opexa TherapeuticsChief Medical Officer Feb 23, 2022 to Mar 16, 2023³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

ZEVRA THERAPEUTICS, INC. ZVRA9,723 shares⁴$100.0K at $10.28Jan 30, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

Jan 30, 2026Sold 4,533 shares at $8.83 of ZEVRA THERAPEUTICS, INC.⁴
Jan 30, 2026Exercised options 11,333 shares of ZEVRA THERAPEUTICS, INC.⁴

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARSPRUCE BIOSCIENCES, INC., Chief Medical Officer
2
SEC EDGARZEVRA THERAPEUTICS, INC., Chief Medical Officer
3
SEC EDGAROpexa Therapeutics, Chief Medical Officer
4
SEC EDGARZEVRA THERAPEUTICS, INC. shares after the filing of Jan 30, 2026